Achieve Life Sciences Inc.

06/29/2022 | Press release | Distributed by Public on 06/29/2022 06:04

Achieve Life Sciences Announces Initiation of Phase 2 ORCA-V1 Clinical Trial Evaluating Cytisinicline for Nicotine e-cigarette Cessation